| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/13/2010 | US20100120664 Modified coagulation factors with prolonged in vivo half-life |
| 05/13/2010 | US20100120632 Methods and Compositions For Sorting and/or Determining Organisms |
| 05/13/2010 | US20100120620 Drought Responsive Promoters HVA22e and PLDdelta identified from Arabidopsis thaliana |
| 05/13/2010 | US20100120155 Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof |
| 05/13/2010 | US20100120154 Method for homologous recombination |
| 05/13/2010 | US20100120153 N-glycosylation mutant of melanoma differentiation associated gene-7 |
| 05/13/2010 | US20100120152 Methods for expression of transgenes |
| 05/13/2010 | US20100120151 enables embryogenic tissue to be detected in vitro thus allows for early discading of non-embryonic tissue; antioxidant; inhibition or retardation of apoptotic processes; tablet or cream form as an antiaging agent; used in generating male sterile plants |
| 05/13/2010 | US20100120143 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 05/13/2010 | US20100120141 Screening methods for compounds that modulate the activity of G-protein coupled receptors |
| 05/13/2010 | US20100120140 Targeted gene delivery for dendritic cell vaccination |
| 05/13/2010 | US20100120125 Bacterial biomineralization of contaminants |
| 05/13/2010 | US20100120124 Systems, methods and microrganisms for antibody production with type iii secretion system |
| 05/13/2010 | US20100120110 Cytochrome p450s and uses thereof |
| 05/13/2010 | US20100120108 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 05/13/2010 | US20100120092 Recombinant proteins and virus like particles comprising l and s polypeptides of avian hepadnaviridae and methods, nucleic acid constructs, vectors and host cells for producing same |
| 05/13/2010 | US20100120091 Subtilase variants |
| 05/13/2010 | US20100120090 MAMMALIAN EXPRESSION VECTOR pUHAB |
| 05/13/2010 | US20100120089 A novel vector and expression cell line for mass production of recombinant protein and a process of producing recombinant protein using same |
| 05/13/2010 | US20100120088 Mutant 6-phosphogluconate dehydrogenase |
| 05/13/2010 | US20100120068 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 05/13/2010 | US20100120052 Orotate Transporter Encoding Marker Genes |
| 05/13/2010 | US20100120048 Assays for short sequence variants |
| 05/13/2010 | US20100120032 Transgenic plant event detection |
| 05/13/2010 | US20100120030 Extracellular serine protease |
| 05/13/2010 | US20100120029 Mutagenesis of aspergillus fungi and genes essential for growth |
| 05/13/2010 | US20100120018 Integrated Active Flux Microfluidic Devices and Methods |
| 05/13/2010 | US20100120015 Method of collecting placental stem cells |
| 05/13/2010 | US20100119691 Expression of human milk proteins in transgenic plants |
| 05/13/2010 | US20100119690 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass in plants |
| 05/13/2010 | US20100119656 Cloning, expression and use of acid lysophospholipases |
| 05/13/2010 | US20100119588 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 05/13/2010 | US20100119551 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2010 | US20100119550 Recombinant multivalent vaccine |
| 05/13/2010 | US20100119547 Recombinant Parainfluenza Virus Expression Systems And Vaccines |
| 05/13/2010 | US20100119546 Vaccine against african horse sickness virus |
| 05/13/2010 | US20100119545 Modified vaccinia ankara virus variant |
| 05/13/2010 | US20100119544 Vaccine |
| 05/13/2010 | US20100119543 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 05/13/2010 | US20100119539 Vaccine against malaria, based on the 200l subuniti of plasmodium vivax msp1 protein |
| 05/13/2010 | US20100119538 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/13/2010 | US20100119532 Composition comprising the N-terminal region of histone H2B of Leishmania - use thereof for inducing an immune response |
| 05/13/2010 | US20100119528 Transport of Biologically Active Molecules into a Cell, Mitochondrion, or Nucleus |
| 05/13/2010 | US20100119522 Combination therapy for the treatment of ocular neovascular disorders |
| 05/13/2010 | US20100119521 Compositions and methods for treating cancer by modulating her-2 and egf receptors |
| 05/13/2010 | US20100119515 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/13/2010 | US20100119511 Light targeting molecules and uses thereof |
| 05/13/2010 | US20100119507 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/13/2010 | US20100119491 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 05/13/2010 | US20100119489 Stimulation of Pancreatic Beta Cell Proliferation |
| 05/13/2010 | US20100119483 Peptide viral entry inhibitors |
| 05/13/2010 | US20100119478 ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE) |
| 05/13/2010 | US20100119477 Psm peptides as vaccine targets against methicillin-resistant staphylococcus |
| 05/13/2010 | US20100119446 Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 05/12/2010 | EP2184864A2 Method and apparatus for data transmission using multiple transmit antennas |
| 05/12/2010 | EP2184609A2 Compositions and methods for treating lung cancer |
| 05/12/2010 | EP2184607A1 Immune response assessment method |
| 05/12/2010 | EP2184369A1 Method for normalisation in electrophoresis |
| 05/12/2010 | EP2184366A2 Method for producing lycopene |
| 05/12/2010 | EP2184365A1 Multi-marked diploid yeast strains for use in measuring eukaryotic chromosome instability |
| 05/12/2010 | EP2184363A1 RNA virus-derived plant expression system |
| 05/12/2010 | EP2184362A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 05/12/2010 | EP2184361A2 Expression cassettes for regulation of expression in monocotyledonous plants |
| 05/12/2010 | EP2184360A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 05/12/2010 | EP2184359A1 Flax (Linum usitatissimum L.) seed-specific promoters |
| 05/12/2010 | EP2184358A2 Canine interleukin 18 and remedies for canine immunological diseases |
| 05/12/2010 | EP2184357A1 Recombinant vector and microorganism for increasing galactose catabolism and methods therefor |
| 05/12/2010 | EP2184356A1 Method of binding protein to support using tamavidin |
| 05/12/2010 | EP2184355A1 Antibody modified with hydrophobic molecule |
| 05/12/2010 | EP2184354A1 Isopropyl alcohol-producing bacterium and method of producing isopropyl alcohol using the same |
| 05/12/2010 | EP2184353A1 Treatment of influenza |
| 05/12/2010 | EP2184352A1 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer and bladder cancer |
| 05/12/2010 | EP2184350A2 Method for obtaining cellulases having improved thermostability |
| 05/12/2010 | EP2184297A1 HLA-G polypeptides and pharmaceutical uses thereof |
| 05/12/2010 | EP2184296A1 Fibroblast growth factor (fgf23) and methods for use |
| 05/12/2010 | EP2184293A2 Suppression of resistance in insects to bacillus thuringiensis cry toxins, using toxins that do not require the cadherin receptor |
| 05/12/2010 | EP2184291A1 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 05/12/2010 | EP2184289A1 Methods for the production of ASLV reverse transcriptases composed of multiple subunits |
| 05/12/2010 | EP2184070A1 HLA-G proteins and pharmaceutical uses thereof |
| 05/12/2010 | EP2184067A1 Severe acute respiratory syndrome DNA vaccine compositions and methods of use |
| 05/12/2010 | EP2184054A1 Small Interfering RNA Delivery |
| 05/12/2010 | EP2183963A1 Method for producing plant with modified flower morphology |
| 05/12/2010 | EP2183381A1 Compositions and methods for producing antibodies having human idiotypes in transgenic birds |
| 05/12/2010 | EP2183378A1 Tailored multi-site combinatorial assembly |
| 05/12/2010 | EP2183373A2 Transgenic plants with increased stress tolerance and yield |
| 05/12/2010 | EP2183372A2 Plants having enhanced yield-related traits and a method for making the same |
| 05/12/2010 | EP2183371A2 Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same |
| 05/12/2010 | EP2183370A1 Production of genetically modified actinomycetes by recombination |
| 05/12/2010 | EP2183369A1 Method for generating stable cell lines expressing high levels of a protein of interest |
| 05/12/2010 | EP2183368A2 Promoterless cassettes for expression of alphavirus structural proteins |
| 05/12/2010 | EP2183367A1 Production of itaconic acid |
| 05/12/2010 | EP2183366A1 Immunogenic polypeptides and monoclonal antibodies |
| 05/12/2010 | EP2183365A2 Sidna against hepatitis c virus (hcv) |
| 05/12/2010 | EP2183362A2 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
| 05/12/2010 | EP2183359A2 Improved methods for protein production |
| 05/12/2010 | EP2183355A1 Compositions and methods for the modification of physiological responses in plants |
| 05/12/2010 | EP2183277A1 Sex-peptides resistant to proteolytic degradation and their use in biological control of insects |
| 05/12/2010 | EP1829972B1 DNA sequences having anti-repressor activity |
| 05/12/2010 | EP1711187B1 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 05/12/2010 | EP1709183B1 Method of modifying plant phenotypes with nonsymbiotic hemoglobin |